CD34 and diabetes mellitus: In conclusion, we have demonstrated the efficacy of CD34+ cell therapy for healing of cutaneous wounds in mice with diabetes, which occurred by resolving inflammation, increasing, angiogenesis, enhancing epithelialization and improving granulation tissue formation.